Samantha Jaglowski
Sr. Scientific Director, CIBMTR · Medical College of Wisconsin Affiliated Hospitals, Inc
Credentials: · · · ·
History
- 2007–2009
- 2004–2007
Internal Medicine
Research
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
New England Journal of Medicine · 2019 · 3,379 citations
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
New England Journal of Medicine · 2020 · 1,512 citations
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib
New England Journal of Medicine · 2014 · 1,075 citations
- SP
34 papers
- SD
34 papers
- JB
31 papers
31 papers
- LA
29 papers
24 papers
23 papers
- YE
23 papers
Clinical trials
- 2015
Lymphocyte Profiles and Activation Status in Patients With Graft-Versus-Host Disease
Principal investigator · Withdrawn
Ohio State University Comprehensive Cancer Center
- 2014
iPad Use in Reducing Anxiety and Depression in Patients Undergoing Bone Marrow Transplant
Principal investigator · Terminated
Ohio State University Comprehensive Cancer Center
- 2010–2014
Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL
Principal investigator · Completed · Phase 1, Phase 2
Pharmacyclics LLC.